APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cardiovascular Interventional Product

Compare research editions
View pricing & licenses

Selected research

Industry Research

Cardiovascular Interventional Product Industry Research Report 2026

29 December 2025136 pages

Choose your research edition.

Industry ResearchCardiovascular Interventional Product Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiovascular Interventional Product Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Cardiovascular Interventional Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiovascular Interventional Product Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiovascular Interventional Product Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Global key players of Cardiovascular Interventional Product include Boston Scientific, Abbott Laboratories, Medtronic plc, TERUMO CORPORATION and NIPRO, etc. Top five players occupy for a share about 75%. North America is the largest market, with a share about 47%, followed by Japan and Europe. In terms of product, Coronary Stent is the largest segment, with a share over 62%. In terms of application, Angina is the largest market, with a share over 60%.

Report Scope

This report quantifies the global Cardiovascular Interventional Product market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

Read the full market overview

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Cardiovascular Interventional Product Market by Company

Boston Scientific

Abbott Laboratories

Medtronic plc

TERUMO CORPORATION

NIPRO

B. Braun Melsungen AG

Cook Medical

MicroPort

Lepu Medical

JW Medical Systems (JWMS)

Intecc

KANEKA

Sinomed

Lifetech

Gore Medical

Cardiovascular Interventional Product Segment by Type

Coronary Stent

PTCA Balloon Catheter

Guide Wire

Other

Cardiovascular Interventional Product Segment by Application

Angina

Miocardial Infarction

Other

Cardiovascular Interventional Product Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiovascular Interventional Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiovascular Interventional Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiovascular Interventional Product.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Cardiovascular Interventional Product manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Cardiovascular Interventional Product by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Cardiovascular Interventional Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cardiovascular Interventional Product Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Cardiovascular Interventional Product Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Cardiovascular Interventional Product Sales Market Share by Manufacturers (2021-2026) Table 8. Global Cardiovascular Interventional Product Revenue of Manufacturers (2021-2026) Table 9. Global Cardiovascular Interventional Product Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Cardiovascular Interventional Product Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Cardiovascular Interventional Product Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Cardiovascular Interventional Product, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Cardiovascular Interventional Product, Product Type & Application Table 14. Global Cardiovascular Interventional Product Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Cardiovascular Interventional Product by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Boston Scientific Company Information Table 19. Boston Scientific Business Overview Table 20. Boston Scientific Cardiovascular Interventional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Boston Scientific Cardiovascular Interventional Product Product Portfolio Table 22. Boston Scientific Recent Developments Table 23. Abbott Laboratories Company Information Table 24. Abbott Laboratories Business Overview Table 25. Abbott Laboratories Cardiovascular Interventional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Abbott Laboratories Cardiovascular Interventional Product Product Portfolio Table 27. Abbott Laboratories Recent Developments Table 28. Medtronic plc Company Information Table 29. Medtronic plc Business Overview Table 30. Medtronic plc Cardiovascular Interventional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Medtronic plc Cardiovascular Interventional Product Product Portfolio Table 32. Medtronic plc Recent Developments Table 33. TERUMO CORPORATION Company Information Table 34. TERUMO CORPORATION Business Overview Table 35. TERUMO CORPORATION Cardiovascular Interventional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. TERUMO CORPORATION Cardiovascular Interventional Product Product Portfolio Table 37. TERUMO CORPORATION Recent Developments Table 38. NIPRO Company Information Table 39. NIPRO Business Overview Table 40. NIPRO Cardiovascular Interventional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. NIPRO Cardiovascular Interventional Product Product Portfolio Table 42. NIPRO Recent Developments Table 43. B. Braun Melsungen AG Company Information Table 44. B. Braun Melsungen AG Business Overview Table 45. B. Braun Melsungen AG Cardiovascular Interventional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. B. Braun Melsungen AG Cardiovascular Interventional Product Product Portfolio Table 47. B. Braun Melsungen AG Recent Developments Table 48. Cook Medical Company Information Table 49. Cook Medical Business Overview Table 50. Cook Medical Cardiovascular Interventional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Cook Medical Cardiovascular Interventional Product Product Portfolio Table 52. Cook Medical Recent Developments Table 53. MicroPort Company Information Table 54. MicroPort Business Overview Table 55. MicroPort Cardiovascular Interventional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. MicroPort Cardiovascular Interventional Product Product Portfolio Table 57. MicroPort Recent Developments Table 58. Lepu Medical Company Information Table 59. Lepu Medical Business Overview Table 60. Lepu Medical Cardiovascular Interventional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Lepu Medical Cardiovascular Interventional Product Product Portfolio Table 62. Lepu Medical Recent Developments Table 63. JW Medical Systems (JWMS) Company Information Table 64. JW Medical Systems (JWMS) Business Overview Table 65. JW Medical Systems (JWMS) Cardiovascular Interventional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. JW Medical Systems (JWMS) Cardiovascular Interventional Product Product Portfolio Table 67. JW Medical Systems (JWMS) Recent Developments Table 68. Intecc Company Information Table 69. Intecc Business Overview Table 70. Intecc Cardiovascular Interventional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Intecc Cardiovascular Interventional Product Product Portfolio Table 72. Intecc Recent Developments Table 73. KANEKA Company Information Table 74. KANEKA Business Overview Table 75. KANEKA Cardiovascular Interventional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. KANEKA Cardiovascular Interventional Product Product Portfolio Table 77. KANEKA Recent Developments Table 78. Sinomed Company Information Table 79. Sinomed Business Overview Table 80. Sinomed Cardiovascular Interventional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Sinomed Cardiovascular Interventional Product Product Portfolio Table 82. Sinomed Recent Developments Table 83. Lifetech Company Information Table 84. Lifetech Business Overview Table 85. Lifetech Cardiovascular Interventional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Lifetech Cardiovascular Interventional Product Product Portfolio Table 87. Lifetech Recent Developments Table 88. Gore Medical Company Information Table 89. Gore Medical Business Overview Table 90. Gore Medical Cardiovascular Interventional Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Gore Medical Cardiovascular Interventional Product Product Portfolio Table 92. Gore Medical Recent Developments Table 93. Global Cardiovascular Interventional Product Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Cardiovascular Interventional Product Sales by Region (2021-2026) & (K Units) Table 95. Global Cardiovascular Interventional Product Sales Market Share by Region (2021-2026) Table 96. Global Cardiovascular Interventional Product Sales by Region (2027-2032) & (K Units) Table 97. Global Cardiovascular Interventional Product Sales Market Share by Region (2027-2032) Table 98. Global Cardiovascular Interventional Product Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Cardiovascular Interventional Product Revenue Market Share by Region (2021-2026) Table 100. Global Cardiovascular Interventional Product Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Cardiovascular Interventional Product Revenue Market Share by Region (2027-2032) Table 102. North America Cardiovascular Interventional Product Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Cardiovascular Interventional Product Sales by Country (2021-2026) & (K Units) Table 104. North America Cardiovascular Interventional Product Sales by Country (2027-2032) & (K Units) Table 105. North America Cardiovascular Interventional Product Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Cardiovascular Interventional Product Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Cardiovascular Interventional Product Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Cardiovascular Interventional Product Sales by Country (2021-2026) & (K Units) Table 109. Europe Cardiovascular Interventional Product Sales by Country (2027-2032) & (K Units) Table 110. Europe Cardiovascular Interventional Product Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Cardiovascular Interventional Product Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Cardiovascular Interventional Product Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Cardiovascular Interventional Product Sales by Country (2021-2026) & (K Units) Table 114. Asia Pacific Cardiovascular Interventional Product Sales by Country (2027-2032) & (K Units) Table 115. Asia Pacific Cardiovascular Interventional Product Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Cardiovascular Interventional Product Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Cardiovascular Interventional Product Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Cardiovascular Interventional Product Sales by Country (2021-2026) & (K Units) Table 119. South America Cardiovascular Interventional Product Sales by Country (2027-2032) & (K Units) Table 120. South America Cardiovascular Interventional Product Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Cardiovascular Interventional Product Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Cardiovascular Interventional Product Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Cardiovascular Interventional Product Sales by Country (2021-2026) & (K Units) Table 124. Middle East and Africa Cardiovascular Interventional Product Sales by Country (2027-2032) & (K Units) Table 125. Middle East and Africa Cardiovascular Interventional Product Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Cardiovascular Interventional Product Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Cardiovascular Interventional Product Sales by Type (2021-2026) & (K Units) Table 128. Global Cardiovascular Interventional Product Sales by Type (2027-2032) & (K Units) Table 129. Global Cardiovascular Interventional Product Sales Market Share by Type (2021-2026) Table 130. Global Cardiovascular Interventional Product Sales Market Share by Type (2027-2032) Table 131. Global Cardiovascular Interventional Product Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Cardiovascular Interventional Product Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Cardiovascular Interventional Product Revenue Market Share by Type (2021-2026) Table 134. Global Cardiovascular Interventional Product Revenue Market Share by Type (2027-2032) Table 135. Global Cardiovascular Interventional Product Price by Type (2021-2026) & (US$/Unit) Table 136. Global Cardiovascular Interventional Product Price by Type (2027-2032) & (US$/Unit) Table 137. Global Cardiovascular Interventional Product Sales by Application (2021-2026) & (K Units) Table 138. Global Cardiovascular Interventional Product Sales by Application (2027-2032) & (K Units) Table 139. Global Cardiovascular Interventional Product Sales Market Share by Application (2021-2026) Table 140. Global Cardiovascular Interventional Product Sales Market Share by Application (2027-2032) Table 141. Global Cardiovascular Interventional Product Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Cardiovascular Interventional Product Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Cardiovascular Interventional Product Revenue Market Share by Application (2021-2026) Table 144. Global Cardiovascular Interventional Product Revenue Market Share by Application (2027-2032) Table 145. Global Cardiovascular Interventional Product Price by Application (2021-2026) & (US$/Unit) Table 146. Global Cardiovascular Interventional Product Price by Application (2027-2032) & (US$/Unit) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Cardiovascular Interventional Product Distributors List Table 150. Cardiovascular Interventional Product Customers List Table 151. Cardiovascular Interventional Product Industry Trends Table 152. Cardiovascular Interventional Product Industry Drivers Table 153. Cardiovascular Interventional Product Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Cardiovascular Interventional Product Product Image Figure 5. Global Cardiovascular Interventional Product Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Cardiovascular Interventional Product Market Size (2021-2032) & (US$ Million) Figure 7. Global Cardiovascular Interventional Product Sales (2021-2032) & (K Units) Figure 8. Global Cardiovascular Interventional Product Average Price (US$/Unit) & (2021-2032) Figure 9. Coronary Stent Product Image Figure 10. PTCA Balloon Catheter Product Image Figure 11. Guide Wire Product Image Figure 12. Other Product Image Figure 13. Angina Product Image Figure 14. Miocardial Infarction Product Image Figure 15. Other Product Image Figure 16. Global Cardiovascular Interventional Product Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Cardiovascular Interventional Product, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Cardiovascular Interventional Product Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Cardiovascular Interventional Product Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Cardiovascular Interventional Product Sales by Region in 2025 Figure 22. Global Cardiovascular Interventional Product Revenue by Region in 2025 Figure 23. North America Cardiovascular Interventional Product Market Size by Country in 2025 Figure 24. North America Cardiovascular Interventional Product Sales Market Share by Country (2021-2032) Figure 25. North America Cardiovascular Interventional Product Revenue Market Share by Country (2021-2032) Figure 26. United States Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Cardiovascular Interventional Product Market Size by Country in 2025 Figure 30. Europe Cardiovascular Interventional Product Sales Market Share by Country (2021-2032) Figure 31. Europe Cardiovascular Interventional Product Revenue Market Share by Country (2021-2032) Figure 32. Germany Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Cardiovascular Interventional Product Market Size by Country in 2025 Figure 43. Asia Pacific Cardiovascular Interventional Product Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Cardiovascular Interventional Product Revenue Market Share by Country (2021-2032) Figure 45. China Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Cardiovascular Interventional Product Market Size by Country in 2025 Figure 54. South America Cardiovascular Interventional Product Sales Market Share by Country (2021-2032) Figure 55. South America Cardiovascular Interventional Product Revenue Market Share by Country (2021-2032) Figure 56. Brazil Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Cardiovascular Interventional Product Market Size by Country in 2025 Figure 60. Middle East and Africa Cardiovascular Interventional Product Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Cardiovascular Interventional Product Revenue Market Share by Country (2021-2032) Figure 62. Egypt Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Cardiovascular Interventional Product Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Cardiovascular Interventional Product Sales Market Share by Type (2021-2032) Figure 68. Global Cardiovascular Interventional Product Revenue Market Share by Type (2021-2032) Figure 69. Global Cardiovascular Interventional Product Price (US$/Unit) by Type (2021-2032) Figure 70. Global Cardiovascular Interventional Product Sales Market Share by Application (2021-2032) Figure 71. Global Cardiovascular Interventional Product Revenue Market Share by Application (2021-2032) Figure 72. Global Cardiovascular Interventional Product Price (US$/Unit) by Application (2021-2032) Figure 73. Cardiovascular Interventional Product Value Chain Figure 74. Cardiovascular Interventional Product Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Cardiovascular Interventional Product Industry Opportunities and Challenges

Scope & coverage.

Types
  • Coronary Stent
  • PTCA Balloon Catheter
  • Guide Wire
  • Other
Applications
  • Angina
  • Miocardial Infarction
  • Other
Companies covered
  • Boston Scientific
  • Abbott Laboratories
  • Medtronic plc
  • TERUMO CORPORATION
  • NIPRO
  • B. Braun Melsungen AG
  • Cook Medical
  • MicroPort
  • Lepu Medical
  • JW Medical Systems (JWMS)
  • Intecc
  • KANEKA
  • Sinomed
  • Lifetech
  • Gore Medical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Cardiovascular Interventional Product Market Size (2021-2032)
  4. 2.2.2 Global Cardiovascular Interventional Product Sales (2021-2032)
  5. 2.2.3 Global Cardiovascular Interventional Product Market Average Price (2021-2032)
  6. 2.3 Cardiovascular Interventional Product by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Coronary Stent
  9. 2.3.3 PTCA Balloon Catheter
  10. 2.3.4 Guide Wire
  11. 2.3.5 Other
  12. 2.4 Cardiovascular Interventional Product by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Angina
  15. 2.4.3 Miocardial Infarction
  16. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Cardiovascular Interventional Product Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Cardiovascular Interventional Product Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Cardiovascular Interventional Product Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Cardiovascular Interventional Product Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Cardiovascular Interventional Product Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Cardiovascular Interventional Product, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Cardiovascular Interventional Product, Product Type & Application
  8. 3.8 Global Manufacturers of Cardiovascular Interventional Product, Established Date
  9. 3.9 Global Cardiovascular Interventional Product Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Boston Scientific
  2. 4.1.1 Boston Scientific Company Information
  3. 4.1.2 Boston Scientific Business Overview
  4. 4.1.3 Boston Scientific Cardiovascular Interventional Product Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Boston Scientific Cardiovascular Interventional Product Product Portfolio
  6. 4.1.5 Boston Scientific Recent Developments
  7. 4.2 Abbott Laboratories
  8. 4.2.1 Abbott Laboratories Company Information
  9. 4.2.2 Abbott Laboratories Business Overview
  10. 4.2.3 Abbott Laboratories Cardiovascular Interventional Product Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Abbott Laboratories Cardiovascular Interventional Product Product Portfolio
  12. 4.2.5 Abbott Laboratories Recent Developments
  13. 4.3 Medtronic plc
  14. 4.3.1 Medtronic plc Company Information
  15. 4.3.2 Medtronic plc Business Overview
  16. 4.3.3 Medtronic plc Cardiovascular Interventional Product Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Medtronic plc Cardiovascular Interventional Product Product Portfolio
  18. 4.3.5 Medtronic plc Recent Developments
  19. 4.4 TERUMO CORPORATION
  20. 4.4.1 TERUMO CORPORATION Company Information
  21. 4.4.2 TERUMO CORPORATION Business Overview
  22. 4.4.3 TERUMO CORPORATION Cardiovascular Interventional Product Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 TERUMO CORPORATION Cardiovascular Interventional Product Product Portfolio
  24. 4.4.5 TERUMO CORPORATION Recent Developments
  25. 4.5 NIPRO
  26. 4.5.1 NIPRO Company Information
  27. 4.5.2 NIPRO Business Overview
  28. 4.5.3 NIPRO Cardiovascular Interventional Product Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 NIPRO Cardiovascular Interventional Product Product Portfolio
  30. 4.5.5 NIPRO Recent Developments
  31. 4.6 B. Braun Melsungen AG
  32. 4.6.1 B. Braun Melsungen AG Company Information
  33. 4.6.2 B. Braun Melsungen AG Business Overview
  34. 4.6.3 B. Braun Melsungen AG Cardiovascular Interventional Product Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 B. Braun Melsungen AG Cardiovascular Interventional Product Product Portfolio
  36. 4.6.5 B. Braun Melsungen AG Recent Developments
  37. 4.7 Cook Medical
  38. 4.7.1 Cook Medical Company Information
  39. 4.7.2 Cook Medical Business Overview
  40. 4.7.3 Cook Medical Cardiovascular Interventional Product Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Cook Medical Cardiovascular Interventional Product Product Portfolio
  42. 4.7.5 Cook Medical Recent Developments
  43. 4.8 MicroPort
  44. 4.8.1 MicroPort Company Information
  45. 4.8.2 MicroPort Business Overview
  46. 4.8.3 MicroPort Cardiovascular Interventional Product Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 MicroPort Cardiovascular Interventional Product Product Portfolio
  48. 4.8.5 MicroPort Recent Developments
  49. 4.9 Lepu Medical
  50. 4.9.1 Lepu Medical Company Information
  51. 4.9.2 Lepu Medical Business Overview
  52. 4.9.3 Lepu Medical Cardiovascular Interventional Product Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Lepu Medical Cardiovascular Interventional Product Product Portfolio
  54. 4.9.5 Lepu Medical Recent Developments
  55. 4.10 JW Medical Systems (JWMS)
  56. 4.10.1 JW Medical Systems (JWMS) Company Information
  57. 4.10.2 JW Medical Systems (JWMS) Business Overview
  58. 4.10.3 JW Medical Systems (JWMS) Cardiovascular Interventional Product Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 JW Medical Systems (JWMS) Cardiovascular Interventional Product Product Portfolio
  60. 4.10.5 JW Medical Systems (JWMS) Recent Developments
  61. 4.11 Intecc
  62. 4.11.1 Intecc Company Information
  63. 4.11.2 Intecc Business Overview
  64. 4.11.3 Intecc Cardiovascular Interventional Product Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Intecc Cardiovascular Interventional Product Product Portfolio
  66. 4.11.5 Intecc Recent Developments
  67. 4.12 KANEKA
  68. 4.12.1 KANEKA Company Information
  69. 4.12.2 KANEKA Business Overview
  70. 4.12.3 KANEKA Cardiovascular Interventional Product Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 KANEKA Cardiovascular Interventional Product Product Portfolio
  72. 4.12.5 KANEKA Recent Developments
  73. 4.13 Sinomed
  74. 4.13.1 Sinomed Company Information
  75. 4.13.2 Sinomed Business Overview
  76. 4.13.3 Sinomed Cardiovascular Interventional Product Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Sinomed Cardiovascular Interventional Product Product Portfolio
  78. 4.13.5 Sinomed Recent Developments
  79. 4.14 Lifetech
  80. 4.14.1 Lifetech Company Information
  81. 4.14.2 Lifetech Business Overview
  82. 4.14.3 Lifetech Cardiovascular Interventional Product Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Lifetech Cardiovascular Interventional Product Product Portfolio
  84. 4.14.5 Lifetech Recent Developments
  85. 4.15 Gore Medical
  86. 4.15.1 Gore Medical Company Information
  87. 4.15.2 Gore Medical Business Overview
  88. 4.15.3 Gore Medical Cardiovascular Interventional Product Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Gore Medical Cardiovascular Interventional Product Product Portfolio
  90. 4.15.5 Gore Medical Recent Developments
5 Global Cardiovascular Interventional Product Market Scenario by Region
  1. 5.1 Global Cardiovascular Interventional Product Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Cardiovascular Interventional Product Sales by Region: 2021-2032
  3. 5.2.1 Global Cardiovascular Interventional Product Sales by Region: 2021-2026
  4. 5.2.2 Global Cardiovascular Interventional Product Sales by Region: 2027-2032
  5. 5.3 Global Cardiovascular Interventional Product Revenue by Region: 2021-2032
  6. 5.3.1 Global Cardiovascular Interventional Product Revenue by Region: 2021-2026
  7. 5.3.2 Global Cardiovascular Interventional Product Revenue by Region: 2027-2032
  8. 5.4 North America Cardiovascular Interventional Product Market Facts & Figures by Country
  9. 5.4.1 North America Cardiovascular Interventional Product Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Cardiovascular Interventional Product Sales by Country (2021-2032)
  11. 5.4.3 North America Cardiovascular Interventional Product Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Cardiovascular Interventional Product Market Facts & Figures by Country
  16. 5.5.1 Europe Cardiovascular Interventional Product Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Cardiovascular Interventional Product Sales by Country (2021-2032)
  18. 5.5.3 Europe Cardiovascular Interventional Product Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Cardiovascular Interventional Product Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Cardiovascular Interventional Product Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Cardiovascular Interventional Product Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Cardiovascular Interventional Product Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Cardiovascular Interventional Product Market Facts & Figures by Country
  41. 5.7.1 South America Cardiovascular Interventional Product Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Cardiovascular Interventional Product Sales by Country (2021-2032)
  43. 5.7.3 South America Cardiovascular Interventional Product Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Cardiovascular Interventional Product Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Cardiovascular Interventional Product Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Cardiovascular Interventional Product Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Cardiovascular Interventional Product Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Cardiovascular Interventional Product Sales by Type (2021-2032)
  2. 6.1.1 Global Cardiovascular Interventional Product Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Cardiovascular Interventional Product Sales Market Share by Type (2021-2032)
  4. 6.2 Global Cardiovascular Interventional Product Revenue by Type (2021-2032)
  5. 6.2.1 Global Cardiovascular Interventional Product Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Cardiovascular Interventional Product Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Cardiovascular Interventional Product Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Cardiovascular Interventional Product Sales by Application (2021-2032)
  2. 7.1.1 Global Cardiovascular Interventional Product Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Cardiovascular Interventional Product Sales Market Share by Application (2021-2032)
  4. 7.2 Global Cardiovascular Interventional Product Revenue by Application (2021-2032)
  5. 7.2.1 Global Cardiovascular Interventional Product Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Cardiovascular Interventional Product Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Cardiovascular Interventional Product Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Cardiovascular Interventional Product Value Chain Analysis
  2. 8.1.1 Cardiovascular Interventional Product Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Cardiovascular Interventional Product Production Mode & Process
  5. 8.2 Cardiovascular Interventional Product Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Cardiovascular Interventional Product Distributors
  8. 8.2.3 Cardiovascular Interventional Product Customers
9 Global Cardiovascular Interventional Product Analyzing Market Dynamics
  1. 9.1 Cardiovascular Interventional Product Industry Trends
  2. 9.2 Cardiovascular Interventional Product Industry Drivers
  3. 9.3 Cardiovascular Interventional Product Industry Opportunities and Challenges
  4. 9.4 Cardiovascular Interventional Product Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst